Notch signaling is required for multiple aspects of cardiovascular development, including arterial-venous differentiation, septation and cushion formation. Despite recognition of the importance of the Notch pathway in normal cardiovascular development, the proximate downstream effectors are not yet known. Likely candidate effectors are members of the hairy and enhancer of split related (hesr) family of bHLH transcription factors. However, mutational analysis of individual hesr genes has so far failed to elucidate their role in all Notch-mediated cardiovascular signaling events. An example of this is evident for mutants of gridlock, the zebrafish counterpart of mouse hesr2, which have vascular defects, whereas mouse hesr2 mutants have only cardiac defects. One possible explanation for these differences could be functional redundancy between hesr family members. Here, we report that mice lacking the hesr1 gene are viable and fertile, whereas knockout mouse of both hesr1 and hesr2 is embryonic lethal at 11.5 days postcoitum (dpc) and recapitulates most of the known cardiovascular phenotypes of disrupted Notch pathway mutants including defects in arterial-venous specification, septation and cushion formation. Taken together, our results demonstrate a requirement for hesr1 and hesr2 in mediating Notch signaling in the developing cardiac and vascular systems. D
Introduction
The cardiovascular system is the first organ system to form during embryogenesis and the cardiac and vascular endothelia play essential roles in this process. During cardiac development, the inner cardiac endothelium regulates the maturation of the outer myocardium, which is required for trabecular formation (Brutsaert et al., 1998) . Coalescence of trabeculations at the apex of the heart results in the formation of a muscular ventricular septum that divides the primitive ventricle into the right and left ventricles early in development (Ben-Shachar et al., 1985) . Luminal endothelial cells in the regions of both the atrioventricular (AV) cushion and outflow tract undergo epithelial-mesenchymal transformation and participate in the formation of valves and membranous septa (Runyan and Markwald, 1983) . During vascular development, after a primary vascular plexus has formed, more vascular endothelial cells are generated, and these form new capillaries by sprouting or splitting from their vessel of origin in a process termed angiogenesis (reviewed in Risau, 1997) . Reciprocal interactions between vascular endothelial cells, vascular mesenchymal cells and the surrounding matrix are essential in this process.
Notch signaling is essential for cardiac and vascular morphogenesis in mice. In the heart, endothelial cells, especially in the AV canal region, express Notch1. Evidence for a requirement of Notch signaling during cardiovascular development came from studies of mice that contain a processing-deficient allele of Notch1. These mice exhibit heart anomalies, including a distended pericardium (Huppert et al., 2000; Timmerman et al., 2004) . Furthermore, a transcriptional co-factor of Notch, RBPJk, expressed in cardiac endothelial cells, has been shown to be essential for epithelial to mesenchymal transformation (EMT) (Timmerman et al., 2004) . Additionally, hypomorphic mutants of Notch2, which is expressed in the myocardium, exhibit a thinning of the myocardial wall (McCright et al., 2002) . Moreover, mice mutants for the Notch ligand, Jagged1, which causes the autosomal dominant disorder Alagille syndrome in humans (Li et al., 1997; Oda et al., 1997) , exhibit embryonic lethality and vascular defects (Xue et al., 1999) and Jagged1 and hypomorphic Notch2 double heterozygous mutants show further defects in heart, eye and kidney development, which parallel the defects observed in Alagille syndrome in humans (McCright et al., 2002) . Additional evidence supporting a role for notch signaling in vascular development stems from the observations that Notch1, Notch3, Notch4, Delta4, Jagged1 and Jagged2 are all expressed in arterial tissues (Krebs et al., 2000; Villa et al., 2001) and mutations in these genes results in vascular defects (Huppert et al., 2000; McCright et al., 2002; Shutter et al., 2000; Xue et al., 1999) .
The hesr family of bHLH transcription factors was identified through its similarity to the hairy and enhance of split (hes) family of genes, which are downstream targets of Notch signaling in Drosophila. In both mouse and human, there are three hesr genes, hesr1-3, (also known as hey, hrt, chf, gridlock, ""or herp) that form a distinct subfamily of bHLH-containing transcriptional repressors from the hes genes. Previous studies of mouse knockouts for hesr2 have shown phenotypes that display dysplastic AV valves, a perimembranous ventricular septal defect (VSD), and a secundum atrial septal defect (ASDII), (Donovan et al., 2002; Gessler et al., 2002; Kokubo et al., 2004; Sakata et al., 2002) . Transthoracic echocardiographies revealed that AV valve regurgitations, due to AV valve hypoplasia, were most likely responsible for heart dysfunction in hesr2 homozygous mutant mice (Kokubo et al., 2004) . However, hesr2-null mice do not show vascular defects, in contrast to mutants of zebrafish gridlock, a homologue of hesr2, which show with coarctation of the aorta (Zhong et al., 2000) . Morpholino knock-down experiments also indicate a role for gridlock in arterial specification (Zhong et al., 2001) . Expression of hesr1 and hesr2 in both the cardiac and vascular endothelium overlap at early stages of the development (Fischer and Gessler, 2003; Iso et al., 2003) (our unpublished data), suggesting possible functional redundancy. We have now generated hesr1 homozygous mutant mice, but they are viable and fertile, and show no obvious phenotype (data not shown). We therefore hypothesized that the phenotypic difference between the mouse and zebrafish hesr2 mutants might be due to differences in the compensatory actions of other hesr gene family members.
Here, we report that mouse embryos lacking both hesr1 and hesr2 are embryonic lethal due to severe cardiovascular malformations. Instead of forming paired left and right ventricles, hesr1/2 double mutants have a single large ventricle, indicating that ventricular septum formation is blocked in the absence of both hesr1 and hesr2. In addition, few cells underwent endocardial to mesenchymal transitions in the developing AV cushions. Finally, arterial differentiation is also defective in hesr1/2 double mutants. These results highlight that essential roles of the hesr genes in the control of critical early events in cardiovascular development and suggest that they are essential downstream targets of Notch signaling in the cardiovascular system.
Material and methods

Knockout mice
To disrupt the hesr1 gene, a targeting vector was constructed with a complete deletion of the bHLH region from exon1 through exon4, (see Supplementary Figure) using hesr1 containing BAC clones derived from the RPCI-22 mouse BAC library (BACPAC resources, CA). The targeting vector was then electroporated into AB1 embryonic stem (ES) cells. Colonies resistant to both neomycin (positive selection) and FIAU (negative selection) were screened by Southern blotting to identify correctly targeted clones. The recombinants were subsequently injected into C57B1/6 blastocysts to generate chimeras. Two independent lines were finally obtained that transmitted the targeted allele through the germ line. For genotyping, a PCR method was developed to detect wild-type alleles, using a 3V forward: CCCTCCCCTCCGTGCTTCTAACCTCAT/3V reverse: CTCTCCCCACCCCACAAAGCAAAGCAG, primer set, and for the targeted allele a 3V reverse/Neo: CGACCACCAAGGCGAAACATC primer set. The neo cassette was removed by crossing the mice with CAG-Cre mice and the genotype was determined using the 3Vreverse/ lacZ: CTCTGTGTCCTCATAAACCCTAACCTCCTT primer set. Mice containing a disrupted hesr2 gene have been described in a separate manuscript (Kokubo et al., 2004) .
Analysis of double mutants
All analyses were conducted on mice with a C57B1/6/ 129Sv mix genetic background. Animals and embryos were genotyped by PCR and in situ hybridizations were performed using a whole mount in situ hybridization system (M&S Instruments). Hematoxylin-eosin (HE) staining and transmission electron microscopic observations were carried out using standard methods (Miyagawa-Tomita et al., 1996) . We used the ApopTag Kit (Intergen, GA) to detect apoptotic cells. Immunohistochemistry was performed using frozen sections with anti-ephrinB2 (R and D), anti-CD31 (PharMingen), or anti-a-smooth muscle actin (SIGMA) primary antibodies, and with alexa468-conjugated anti-rat or mouse IgG (Molecular Probes) as a secondary antibody. The corresponding signals were observed with an Olympus fluorescence microscope system.
Results
The hesr1
À/À /2 À/À shows embryonic lethal at around 10.5 dpc To investigate the respective roles of hesr1 and hesr2 in cardiovascular development in the mouse, we intercrossed hesr1 +/À /2 +/À mice. At weaning, however, no double homozygous mutant was found (Table 1) , suggesting that combined homozygosity at the hesr1 and hesr2 loci results in embryonic lethality. Although the number of hesr1
À/À mice obtained was significantly reduced, some were found to be both viable and fertile, as was previously observed for hesr2 À/À single knockout mice. To define the stage at which the double mutant lethality was occurring, timed pregnant matings were set up and hesr1 À/À /2 À/À embryos were isolated at the expected frequency until 10.5 dpc (Table 1) 
embryos were observed beyond 11.5 dpc, indicating that the double mutants die prior to this stage. At 10.5 dpc, hesr1 À/À /2 À/À homozygous embryos were easily recognized by their poorly formed telencephalic regions and small first and second pharyngeal arches, as well as by heart malformations and hemorrhaging (Figs. 1A and B) . These defects are therefore likely to be responsible for the embryonic lethality observed in hesr1 À/À /2 À/À mice.
display anomalies in heart development
Since previous studies of knockout mice have shown that hesr2 has an important role in cardiac development, particularly in the development of cardiomyocytes and in AV valve formation, we first focused our analysis on heart anomalies in hesr1 (Figs. 2D and F) . During chamber formation, the ventricular wall, accompanied by the proliferation and accumulation of cardiomyocytes, gives rise to two layers corresponding to the sub-epicardial compact and sub-endocardial trabecular zones. Until 9.5 dpc, hesr1 À/À /2 À/À hearts with d-ventricular looping showed a normal-sized ventricular chamber containing both the compact and trabecular zones (Figs. 1G-J). These observations suggested that in hesr1/2 double mutants, the cardiomyocytes in the ventricle could successfully divide into compact and trabecular zones, but that trabecular zone cells are selectively lost at a later stage. We thus speculated that apoptosis might be a contributing factor to this phenotype. Indeed, many TUNEL-positive cells were found in the trabecular zone but not in the compact zone at 10.0 dpc (Figs. 1K and L), although TUNNEL-positive cells were not detected earlier at 9.5 dpc (data not shown). To further characterize the nature of these cardiomyocyte defects, the microstructure of the cardiomyocytes was further analyzed via transmission electron microscopy. Disorganized cardiomyocytes with fewer myofibrils, and with swollen and irregular-shaped mitochondria, were observed in hesr1 À/À /2 À/À mutants (Figs. 1M and N). These observations suggest that poor trabecular formation results in defects in cardiac chamber development.
Endocardial cushion development is essential for AV valve formation. In the AV cushions, cardiac endothelial cells undergo epithelial-mesenchymal transformation and participate in the formation of valves and membranous septa. Our analysis of hesr2 single mutants showed that AV valve regurgitations due to hypoplasia of the valves were most the likely cause of heart dysfunction in these mutant mice, suggesting that hesr2 functions in either the formation or maintenance of the AV valve. Our current studies favor the former possibility. At 9.5 dpc, epithelial-mesenchymal transformations in the AV canal occurred normally and on schedule in the hesr +/À /2 +/À embryo (Fig. 1O ). In contrast, Table 1 Numbers of progeny obtained by intercrossing hesr1 and hesr2 mutants 12 (9) 25 (18) 4 (9) 23 (18) 37 (36) 10 (18) 17 (9) 16 (18) 0 (9) 12 155 10.5 dpc (+/À,
19 (22) 20 (22) 21 (22) 23 (22) 7 90 Genotypes of the progeny from the intercross between hesr1 +/À /2 +/À mice, or between hesr1 À/À /2 +/À and hesr1
/2 À/À mice were examined at day 10 postpartum (dpp) or at day 10 postcoitum (dpc), respectively. hesr1
/2 À/À mice were not detected at 10 dpp, but were evident at 10 dpc as expected. The predicted numbers are parenthesized in the panel.
hesr1 À/À /2 À/À embryos failed to undergo cardiac endothelial cell transformation although the AV cushion was enriched in extracellular matrix (Fig. 1P) . These observations suggest that both hesr1 and 2 play redundant roles in epithelial-mesenchymal transformation during AV valve formation.
Left-right ventricle identity is unaffected in the hesr1
In the hesr1 À/À /2 À/À mutant hearts, only a single ventricle was formed at the gross level. This lack of leftright ventricular formation could be due to either an inability to specify either the left or right ventricles. Alternatively, the ventricular defects could be due to a failure to undergo morphogenetic changes required for ventricular septation. To test these possibilities, we examined the expression of marker genes for cardiac development and for ventricular right-left polarity. Expression of nkx2.5, the earliest gene expressed in the cardiac lineage (Harvey, 1996; Lyons et al., 1995) , was normal in hesr1 À/À /2 À/À hearts (Figs. 2A and B), indicating that general cardiac cell type specification was unaltered. Additionally, the expression of ehand, which is normally only detected in the left ventricle at 10.5 dpc ( Bao et al., 1999; Srivastava et al., 1997) , was restricted to the left side of the ventricle in the hesr1/2 double knockout mice (Figs. 2C and D) , indicating the left side of the ventricle was correctly specified. Transcription of dhand normally occurs in both ventricles and is then enhanced in the right ventricle (Srivastava et al., 1995; Yamagishi et al., 2000) , but was significantly reduced in the hesr1 Figs. 2Ea and Fa) . In addition to the heart, dhand expression is reduced even other regions including the limb bud, in which the normal posterior restricted domain of dhand expression is not observed in the hesr1 À/À /2 À/À mutant embryos. These results may indicate that Notch signaling and/or hesr1/2 function is involved in the AP specification of limb bud (Figs. 2Fb and Eb). In the hesr1 À/À /2 À/À heart, Irx4, a ventricle-specific homeobox gene, was normally expressed (Figs. 2G and H) , and expression of the atrial and ventricular muscle-specific differential markers, MLCa and MLCv (Kubalak et al., 1994) , was also normal, indicating that atrial and ventricular specification and terminal differentiation were unaffected (Figs. 2I-L) . We conclude therefore that hesr1 and hesr2 are essential for myocardial trabecular proliferation of the ventricle rather than for the establishment of the right-left polarity of the cardiac chamber.
The hesr1
À/À /2 À/À embryos display vascular defects
The hesr2 single mutants do not show vascular defects (Donovan et al., 2002; Gessler et al., 2002; Kokubo et al., 2004; Sakata et al., 2002) . On the other hand, mutation of zebrafish gridlock, a homologue of hesr2, is associated with coarctation of the aorta (Zhong et al., 2000) . Expression of hesr1 and hesr2 in the vascular endothelium is found to overlap at an early stage of development (Fischer and Gessler, 2003; Iso et al., 2003) (our unpublished data). We thus hypothesized that the phenotypic difference between the mouse and zebrafish mutants was due to differences in the compensatory actions of the hesr gene family members. Defects in blood vessel development were also evident in hesr1 À/À /2 À/À embryos. In yolk sacs, large blood vessels were not formed in the double mutants (Fig. 3B) . In contrast, in wild-type embryos and in single knockout hesr1 or hesr2 mutants at E10.5, remodeling of vessels occurs to form larger vessels and blood circulation commences in the yolk sac (Fig. 3A) . In the hesr1/2 double mutants, small blood vessels in the yolk sac itself were present (Fig. 3D) , suggesting that hesr1 and hesr2 are redundantly required for the remodeling of vessels in the yolk sac. Additionally, in the hesr1/2 double mutant embryos, as seen for hesr1 or hesr2 single mutants, large vessels, including cardiac vein and dorsal aorta, were normally positioned following ink injection and HE staining analysis (Figs. 3E-H) . However, ink injection into both the vitelline artery and veins could not directly reach the cardinal vein in the double mutants but instead, the ink filled several small vessels connecting the dorsal aorta and cardinal vein (red arrow in Fig. 3F) .
Histologically, the cell layers surrounding the arteries were thinner in the double mutants than in the corresponding double heterozygotes, which prompted us to speculate that hesr1/2 double mutants have arterial specification defects. To test this possibility, we examined the expression of Ephrin-B2 and smooth muscle actin (SMA), both of which are expressed in the mesenchyme surrounding the endothelium of developing arteries, but not in developing veins at this stage of embryogenesis and thus can distinguish arteries and veins. In hesr1/2 double mutants, we observed a large vessel in the position of the dorsal aorta that is prominently stained by PECAM-1 (Figs. 3I, L) . Unlike wild-type or single mutant embryos, hesr1/2 double homozygous mutants do not express either SMA or Ephrin-B2, indicating that arterial formation requires either hesr1 or hesr2 activity. Hence, the roles of the hesr gene family in arterial-venous differentiation are conserved between zebrafish and mouse. 
Discussion
Our results indicate that the Notch signaling pathway, via the hesr1 and hesr2 effectors, plays an important role in cardiac morphogenesis and in angiogenesis. hesr1 À/À /2 À/À mice have defects in myocardial trabeculation and cardiac endothelial cell transformation, as well as in angiogenesis.
Although there are arguments as to whether the cardiac defects or the vascular defects are primary or secondary to each other, both defects could occur independently. In support of a primary role for hesr1 and hesr2 in vascular development, small blood vessels were present in the yolk sac, and blood vessels for great arteries or veins themselves are formed in the hesr1
/2 À/À embryos, and blood circulation was detected up to at least 10.0 dpc. The major defect we found in the vasculature of the hesr1 À/À /2 À/À embryos was in the specification of artery vs. vein, which is detected as early as 9.5 dpc in wild-type or single-mutant embryos. The early development of the cardiac and vascular systems occurs independently until circulation starts about at 9.0 dpc. Thus, we think that it is unlikely that the defect in arterial-venous specification that we observe in the hesr1 À/À /2 À/À mutants is secondary to cardiac defects. With respect to whether the cardiac defects we observe in the hesr1 À/À /2 À/À mutants are direct or indirect, it should be noted that since endocardial transformation and myocardial differentiation occur after cardiac contractions initiate, it is therefore possible that these processes may be affected indirectly by defects in blood circulation. However, we have observed cardiac anomalies in hesr2-single knockout mice without any obvious defects in the vasculature. Collectively favors the idea that the defects we observed in the heart and the arteries of the hesr1 À/À /2 À/À mutants are primary defects in each system. However, we cannot exclude the possibility that some defects are secondary and we will require tissue-specific deletion of hesr genes in cardiac and/or vascular tissues to address the possibility that the phenotypes we observe are indirect.
Synergistic functions of hesr1 and hesr2 in heart development
The hesr1 À/À /2 À/À embryonic hearts had little EMT in the AV cushion tissue, whereas the hesr1 single mutant displayed no heart anomalies (our unpublished data), although some hesr2 single mutants showed dysfunction of the AV valves (Kokubo et al., 2004) . This indicates that hesr1 and hesr2 are necessary for EMT, but also they can compensate for each other in this process. TGFh2, which is restricted to the AV canal myocardium, was shown to be downregulated in the RBPJk mutants (Timmerman et al., 2004) . In hesr1
À/À embryonic hearts, expression of TGFh2 is reduced (Supplemental Fig. S2 ), suggesting that endocardial Notch activity somehow affects myocardial TGFh2 expression, likely through hesr1 and hesr2. However, hesr2 and/or hesr1 are unlikely to be sufficient to induce EMT in the AV cushion tissue as this transformation fails to occur in RBPJk mutants, even though hesr2 expression is maintained in this mutant (Timmerman et al., 2004) . We speculate that other gene(s) may be activated by Notch1/RBPJk that, together with hesr1 and hesr2, are necessary for the induction of EMT. In this context, the zinc finger transcription factor snail is a likely candidate since the expression is known to be downregulated in RBPJk-null embryonic heart and it can repress E-cadherin expression to induce EMT in epithelial tumor cells (Timmerman et al., 2004) . In addition, BMP2 is also know to be involved in EMT (Keyes et al., 2003; Sugi et al., 2004) and cross talk with Notch and BMP2 signaling has been suggested in this context (Takizawa et al., 2003) . Recent studies have shown that hesr1 expression could be synergistically activated by BMP and Notch signaling (Itoh et al., 2004) . Expression of bmp2 is normally detected in the atrium through the AV canal in both hesr1 +/À /2 +/À and hesr1 À/À /2 À/À embryonic hearts (Supplemental Fig. S2 ), however, this BMP signal may not be processed properly in the absence of hesr1 and hesr2, which might result in the suppression of EMT. Further studies will be required to elucidate the molecular mechanism underlining EMT with regard to Notch and BMP signaling and hesr1/2 function.
The hesr1
/2 À/À hearts displayed a hypomorphic ventricular trabecular zone. Although a mild cardiomyocyte defect was seen in the hesr2 À/À single mutant, the formation of the trabecular zone itself was not affected in either of the hesr1 or hesr2 single knockout mutants. It has been previously suggested that the inner cardiac endothelium regulates maturation of the outer myocardium and that this is required for trabecular formation (Brutsaert et al., 1998 ). Our studies demonstrate that expression of hesr1 in endocardial cells and of hesr2 in myocardial cells are required for trabecular formation. In either Notch1 or RBPJk mutants, a myocardial defect was not reported, although Notch2 is expressed in the myocardial cells and its hypomorphic mutant has been shown to exhibit a thinning of the myocardial wall (McCright et al., 2002) . The defect in ventricular formation in the hesr1 À/À /2 À/À embryonic heart showed a more severe phenotype than this, suggesting that there may be a similar functional role between Notch1 expressed in endocardial cells and Notch2 in myocardial cells.
hesr1 has been reported to be a downstream target of Notch1 signaling through the RBPJk transcription factor in vitro (Iso et al., 2002) . Since Notch1, RBPJk and hesr1 are co-expressed in the endocardium and hesr1 expression was absent in the RBPJk mutant (Timmerman et al., 2004) , this suggested that hesr1 should be activated by Notch1 through RBPJk in vivo. The regulation of hesr2, however, appears not to be solely dependent on Notch1 and RBPJk, and since its expression is not affected in the RBPJk mutant, its expression in these tissues is must be controlled via another mechanism. Of particular interest in this regard is the expression of Notch2 in the myocardium (McCright et al., 2002) , which is similar to that of hesr2, suggesting that Notch2 might play a role in hesr2 regulation.
Of further interest is the control mechanism by which hesr proteins modulate cardiovascular development. Information of downstream targets of hesr proteins still remains uncertain. From our studies, one possible downstream target of hesrs is dhand, since the expression of dhand was reduced in the hesr1 À/À /2 À/À embryonic heart. Mice lacking dhand have a single ventricle that exhibit hypotrabeculation and aortic arch defects and die by 11.0 dpc due to the heart failure (Srivastava et al., 1995; Yamagishi et al., 2000) . Therefore, simple explanation for phenotype of the hesr1
À/À heart might be due reduced dhand expression. In this context, it is interesting that the expression level and/or pattern of dhand is altered even in other regions such as pharyngeal arch, limb bud and lateral mesoderm. Since hesr proteins have been shown to function in vitro as transcriptional repressors, regulation of dhand expression by hesr1 and/or hesr2 may be indirect. Further analysis will be necessary to identify the mechanism of how dhand is regulated through either Notch signaling or hesrs proteins.
The synergistic functions of hesr1 and hesr2 in vascular development
The hesr gene family is composed of three members and their expression overlaps in the vasculature, especially in the aorta. In this report, we demonstrate a requirement for hesr1 and hesr2 in vascular and cardiac development, raising the question of whether hesr3 is unable to compensate for the combined loss of hesr1 and hesr2. One possibility is that hesr3 is unable to substitute for hesr1 and hesr2 function. Alternatively, the expression of hesr3 may be altered in hesr1 À/À /2 À/À mutants. To distinguish between these possibilities, we examined whether hesr3 is expressed in the hesr1 À/À /2 À/À embryos by in situ hybridization analysis. We found that the expression of hesr3 is significantly reduced in the hesr1 À/À /2 À/À embryos (Supplemental Fig.  S3 ). Although the mechanism of hesr3 downregulation mediated by hesr1 and/or hesr2 remains uncertain, this downregulation of hesr3 explain why hesr3 does not compensate for hesr1 and hesr2 in the hesr1 À/À /2 À/À mutant. Notch signaling regulates many aspects of cell-fate decisions and of particular relevance to this report plays a critical role in vascular development, especially in remodeling and in arterial-venous specification (Krebs et al., 2000) , may act together with ephrinB2 and EphB4 in arterialvenous specification (Lawson et al., 2001; Shawber et al., 2003) . Eph receptor tyrosine kinases and their transmembrane ephrinB ligands are expressed in the developing circulatory system, and mice lacking either ephrinB2 or EphB4 have similar phenotypes to hesr1 À/À /2 À/À mice, including defects in angiogenic remodeling and poor myocardial trabeculation. Additionally, several studies have now suggested that ephrin-Eph signaling is required for angiogenesis (Adams et al., 1999; Gerety and Anderson, 2002; Gerety et al., 1999; Wang et al., 1998) . Reduced expression of ephrinB2 was also seen in hesr1 À/À /2 À/À mice. These findings suggest that ephrin-Eph signaling, particularly ephrinB2 expression, could be regulated, either directly or indirectly, by Notch signaling via the hesr genes during cardiovascular development. Further analysis will be necessary to identify the signaling pathways involved in the endothelial cells of the developing cardiovascular system.
